A panel of leading anesthesiologists and technical experts convene to discuss the known benefits of low flow anesthesia, including the potential for reducing anesthetic waste, leading to cost savings and reduced greenhouse gas emissions. They will also highlight findings from the "MASTER Trial", a US, multicenter, prospective, randomized, controlled trial of target control low flow anesthesia software, to spark discussion on the accuracy and efficiency of the technology, as well as reported clinician experience.